These results suggest that TYMP is associated with poor prognosis and functions as an oncogene by promoting malignant behaviors in ccRCC, whereas GCNT4, linked to favorable clinical outcomes, exhibits tumor-suppressive roles by inhibiting proliferation, migration, and invasion. Here, GCNT4 is linked to nonpapillary renal cell carcinoma.